designer491
- Teva Pharmaceutical (NYSE:TEVA) announced that it would get rid of Teva-Takeda, its commercial venture in Japan, in JKI Co., established by a fund managed by private equity firm J-Will Partners Co., Ltd.
- According to the agreement, all shares of Teva Takeda Pharma Limited and its
